Patents-Review.com
🔗 Permalink
Inventor profile of:

Xiaolin Li

City:

Shanghai

Country:

China

Published Applications:

25

Last publication date:

2024-10-03

Top Assignees for applications by Xiaolin Li

The entities that hold a legal rights for patent applications filed by inventor Li Xiaolin:

Recent patent applications by Li Xiaolin

Xiaolin Li from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-03
US20240327446A1
Chemistry; metallurgy

DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF

 #2 | 2024-08-29
US20240287117A1
Chemistry; metallurgy

DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF

 #3 | 2024-08-08
US20240262837A1
Chemistry; metallurgy

DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF

 #4 | 2024-07-04
US20240217949A1
Chemistry; metallurgy

COMPOUND FOR USE IN RETINAL DISEASES

 #5 | 2023-11-16
US20230365503A1
Chemistry; metallurgy

CRYSTAL FORM OF PYRIDINYLPHENYL COMPOUND AND PREPARATION METHOD THEREFOR

 #6 | 2023-06-08
US20230174524A1
Chemistry; metallurgy

AMINOPYRIDINE COMPOUND

 #7 | 2023-06-08
US20230174489A1
Chemistry; metallurgy

Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound

 #8 | 2022-05-05
US20220133744A1
Human necessities

COMPOSITION OF LANOSTEROL PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

 #9 | 2022-04-28
US20220127243A1
Chemistry; metallurgy

Compound for use in retinal diseases

 #10 | 2022-02-03
US20220033391A1
Chemistry; metallurgy

Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereof

 #11 | 2022-01-27
US20220024880A1
Chemistry; metallurgy

Process route of compound of formula (IV), crystal form and preparation method therefor

 #12 | 2021-08-12
US20210246158A1
Chemistry; metallurgy

Crystal form of lanosterol prodrug compound and application thereof

 #13 | 2021-07-01
US20210198220A1
Chemistry; metallurgy

SSAO inhibitor

 #14 | 2020-08-20
US20200261453A1
Human necessities

Crystal form of orexin receptor antagonist compound, and preparation method and application thereof

 #15 | 2020-08-20
US20200261452A1
Human necessities

Crystal form of orexin receptor antagonist compound, and preparation method and application thereof

 #16 | 2020-08-13
US20200253972A1
Human necessities

Crystal form of orexin receptor antagonist compound, and preparation method and application thereof

 #17 | 2020-07-23
US20200231622A1
Chemistry; metallurgy

Method for preparing steroid derivative FXR agonist

 #18 | 2020-07-23
US20200231621A1
Chemistry; metallurgy

Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof

 #19 | 2020-04-16
US20200115352A1
Chemistry; metallurgy

SSAO inhibitor

 #20 | 2019-12-05
US20190373422A1
Electricity

Call record synchronization method, cloud platform, and terminal

 #21 | 2019-08-22
US20190256548A1
Chemistry; metallurgy

Lanosterol prodrug compound and preparation method therefor and use thereof

 #22 | 2018-11-01
US20180312512A1
Chemistry; metallurgy

Crystal form, preparation method and intermediate of dihydropyrido ring compound

 #23 | 2018-08-23
US20180235965A1
Human necessities

Crystal form of orexin receptor antagonist compound, and preparation method and application thereof

 #24 | 2017-07-13
US20170197986A1
Chemistry; metallurgy

Dihydropyrimido fused ring derivative as HBV inhibitor

 #25 | 2015-01-15
US20150013847A1
Chemistry; metallurgy

Method for producing silicon steel normalizing substrate
InventorID:

1032587 ⎘